Research Article - (2023) Volume 17, Issue 2
Received: 01-Feb-2023, Manuscript No. jmgm-23-88596;
Editor assigned: 03-Feb-2023, Pre QC No. P-88596;
Reviewed: 15-Feb-2023, QC No. Q-88596;
Revised: 22-Feb-2023, Manuscript No. R-88596;
Published:
28-Feb-2023
, DOI: 10.37421/1747-0862.2023.17.592
Citation: Wang, Dan, Jian Sun and Yiming Chen, et al. “A Novel Compound Heterozygous Variant of SLC12A3 Gene May Contribute to Gitelman Syndrome.” J Mol Genet Med 17 (2023): 592.
Copyright: © 2023 Wang D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The article entitled “A Novel Compound Heterozygous Variant of SLC12A3 Gene May Contribute to Gitelman Syndrome” has been accepted for publication in the Journal of Molecular and Genetic Medicine considering the statements provided in the article as personal opinion of the author which was found not having any conflict or biasness towards anything. As the article was a perspective one, information provided by the author was considered as an opinion to be expressed through publication.
Soon after the acceptance of the paper, we witnessed some serious concerns and many of them argued that the paper is a personal perspective and had not discussed any relevant ethical issue considered under the journal scope. Moreover, the paper is neither innovative nor thought provoking.
Publisher took decision to make the article online solely based on the reviewers suggestion which considered the article not but a personal opinion of the author. However, it is found that the article has some unavoidable mistakes and issues, therefore, being retracted from the journal.
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report
